Search Tag: cancer diagnosis
2024 26 Jul
The European Commission has approved, under EU State aid rules, a €2 billion Dutch measure to support the PALLAS project aimed at producing medical radioisotopes for cancer diagnosis and treatment. The measure contributes to ensuring security of supply of essential and live-saving medicines in line with the Pharmaceutical Strategy for Europe...Read more
2024 09 Dec
<marquee behavior="slide" direction="left" scrollamount="30"> <h2 style="text-align: center;"><font color="#000099"><b>Find ESMO On Social Media</b> </font></h2><div style="text-align: center;"><a href=https://www.twitter.com/myesmo target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=65 height=65></a><Read more
2024 17 Feb
Delays in the diagnosis of skin cancer, attributed to the COVID-19 lockdowns, have resulted in an estimated 100,000 years of life being lost and a financial impact of €7.1 billion across Europe, a recent study suggests. This research, disclosed last Friday in the Jama Network Open journal, underscores the severe outcomes of the 2020 and...Read more
2015 07 Apr
Physicians are taught to deliver the results of patients’ biopsies in person, but a survey of patients at three US melanoma clinics indicates that many patients prefer an expedient phone call to the longer wait associated with a face-to-face follow-up visit. “We thought they would want it to be in person or by email, but it turned out that the phone...Read more
2015 26 Feb
Many physicians struggle to deliver bad news to cancer patients. They must balance the need to honestly inform patients about their prognoses while expressing empathy. According to new research, cancer patients who are given an optimistic message from their doctors which includes possible future treatment options are more likely to perceive a higher...Read more
2014 25 Apr
The agreement includes CE Mark performance evaluation and doubles the Hospital’s prospective trial of 20 cancers, adding a range of additional vital background work VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, has announced that VolitionRx has extended its agreement...Read more
2014 07 Feb
Currently being developed by University of Washington scientists and engineers, a novel, credit-card sized, low cost device could assist pathologists in their analysis of biopsies and the subsequent diagnosis of pancreatic cancer in an earlier and faster manner than ever before. The prototype is able to conduct basic steps required for processing...Read more